Bronchoalveolar Lavage in Recovered From COVID-19 Pneumonia
Bronchoalveolar Lavage
About this trial
This is an interventional diagnostic trial for Bronchoalveolar Lavage focused on measuring Bronchoalveolar lavage, COVID-19 Pneumonia
Eligibility Criteria
Inclusion Criteria: Patients with persistent pulmonary infiltrate one month after discharge from isolation building at Mansoura university hospitals, previously tested positive for SARS-CoV-2 infection by real-time PCR on nasopharyngeal swab during admission, discharged and discontinued transmission based precautions according to CDC guidance: Symptom-Based Strategy for Discontinuing Transmission-Based Precautions (CDC, 2020) Patients with mild to moderate illness who are not severely immunocompromised: At least 10 days have passed since symptoms first appeared and At least 24 hours have passed since last fever without the use of fever-reducing medications and Symptoms (e.g., cough, shortness of breath) have improved Patients with severe to critical illness or who are severely immunocompromised1: At least 10 days and up to 20 days have passed since symptoms first appeared and At least 24 hours have passed since last fever without the use of fever-reducing medications and Symptoms (e.g., cough, shortness of breath) have improved Consider consultation with infection control experts Exclusion Criteria: Age: patients less than 18 years old. Patient refuse to undergo bronchoscopy. Patients unfit for bronchoscopy (hemodynamic instability, recent myocardial infarction, severe hypoxia, uncooperative patient, severe bleeding disorder). Patients known to have chronic airway pulmonary diseases or interstitial lung diseases
Sites / Locations
- Mohamed AbdElmoniem
Arms of the Study
Arm 1
Experimental
Recovered From COVID-19 Pneumonia
Bronchoalveolar Lavage in Recovered From COVID-19 Pneumonia